GlassScriptPhysician profile
Paul D Friedman
NPI 1780605253
$1,146.19
in general payments reported to CMS, 2019-2025
12 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.34 · 2020: $191 · 2021: $19.89 · 2022: $16.88 · 2023: $528 · 2024: $180 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $450 · Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $450.00 |
| Food and Beverage | $427.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leica Microsystems INC. | $483.44 | 2022-2024 | Hydromark Breast Biopsy Site Marker |
| Bard Peripheral Vascular, INC. | $285.56 | 2019-2024 | Senomark Ultracor Breast Tissue Marker |
| Glaxosmithkline, LLC. | $77.45 | 2024-2025 | Trelegy Ellipta, Nucala |
| Hologic Sales and Service, LLC | $73.41 | 2023-2025 | Magseed, Magtrace, Localizer |
| Merit Medical Systems INC | $53.86 | 2025 | Savi Scout |
| Inspire Medical Systems, INC. | $48.51 | 2023-2024 | Inspire |
| Philips North America LLC | $30.88 | 2024-2025 | Vest Therapy Und, (8874) Incourage |
| Genzyme Corporation | $30.18 | 2024 | |
| Azurity Pharmaceuticals, INC. | $18.99 | 2025 | Alvesco |
| Hologic INC | $18.30 | 2020 | |
| Baxter Healthcare | $13.69 | 2025 | |
| Siemens Medical Solutions USA, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.